Document:

10.26 Croxford Separation and Release

SEPARATION AND RELEASE AGREEMENT
Philip Croxford
11128 Harbour Estates Circle
Fort Myers, Florida 33908

Dear Phil:
This Separation and Release Agreement (this "Release Agreement") confirms the terms of the separation of your employment from LifeCell Corporation and any of its affiliates and subsidiaries (the "Company").  
Termination of Employment
1.You and the Company have reached a mutual agreement that your employment with the Company ended effective September 24, 2014 (the "Separation Date").  As of the Separation Date, you were no longer an employee or officer of the Company, and you hereby resign from any and all employment and managerial positions, boards and officer, director or trustee positions, if any, with the Company as of the Separation Date.  You also hereby agree to execute any other documents reasonably necessary to effectuate such resignations.  Provided the Company requests you to perform services from the date of this Release Agreement through the Separation Date, you shall, in the Company’s sole discretion, (a) assist with the transitioning of your duties to a successor and (b) be available at reasonable times to respond to any questions that the Company may have regarding its business.  In the sole discretion of the Company, with reasonable advance notice, you will perform these services on Company premises or by telephone.
2.As of the Separation Date, you ceased to participate in all of the Company’s benefit plans (except as provided by COBRA).
3.You are hereby advised and encouraged by the Company to consult with your own independent counsel before signing this Release Agreement.
Separation Payment 
4.Subject to your compliance with the terms and conditions of this Release Agreement, and provided that you do not revoke your consent to this Release Agreement as permitted by Paragraph 22 of this Release Agreement, the Company shall, in accordance with the agreed upon separation terms pay, or cause to be paid, to you, in full satisfaction of all rights and obligations of the Company:
(a)    a one-time separation payment of Four Hundred Thirty-Nine Thousand Eight Hundred Seventy-Five Dollars and No Cents ($439,875.00), less all amounts required to be withheld by law, including, but not limited to, any applicable federal, state or local taxes (the “Severance Payment”) to be paid within five (5) business days of the Effective Date (as defined in Paragraph 22 of this Release Agreement); 
(b)    a one-time payment of Three Hundred Seven Thousand Nine Hundred Twelve Dollars and Fifty Cents ($307,912.50), less all amounts required to be withheld by law, including, but not limited to, any applicable federal, state or local taxes, representing your 2014 target AIB (“Target AIB”) to be paid within five (5) business days of the Effective Date (as defined in Paragraph 22 of this Release Agreement); and
(c)    if you timely elect health insurance continuation coverage at the same, or a lower, level of coverage as you elected prior to the Separation Date, you will be reimbursed for COBRA premiums 

at the employee only rate until the earliest of: (i) twelve (12) months following the Separation Date; (ii) the date you fail to make timely payment of COBRA premiums and/or terminate your election of COBRA coverage; and (iii) the date you become eligible for comparable health insurance coverage (as an employee or otherwise), that does not contain any exclusion or limitation with respect to any preexisting condition (the “COBRA Payments”).  You acknowledge that the Company’s reimbursement of the COBRA premium made by you will be taxable income to you.  
The payment(s) set forth in Paragraphs 4(a)-(c) above are expressly contingent upon your execution, delivery and non-revocation of this Release Agreement, as provided in Paragraph 22.  You acknowledge that you are not otherwise entitled to receive the payment(s) set forth in Paragraphs 4(a)-(c) above, which exceed anything of value to which you are otherwise entitled from the Company, and agree that you will not seek anything further from any of the Releasees.  
Releases; Representations; Covenant Not to Sue
5.You, for yourself and successors, assigns, executors and administrators, now and forever hereby release and discharge the Company, together with its respective past and present parents, subsidiaries, and affiliates, together with each of their officers, directors, stockholders, partners, employees, agents, representatives, attorneys (in each case, individually and in their official capacities) and employee benefit plans (and such plans’ fiduciaries, agents, administrators and insurers, individually and in their official capacities), and each of their subsidiaries, affiliates, estates, predecessors, successors, and assigns (collectively, the "Releasees") from any and all rights, claims, charges, actions, causes of action, complaints, sums of money, suits, debts, covenants, contracts, agreements, promises, obligations, damages, demands or liabilities of every kind whatsoever, in law or in equity, whether known or unknown, suspected or unsuspected (collectively, "Employee Claims") which you or your executors, administrators, successors or assigns ever had, now have or may hereafter claim to have by reason of any matter, cause or thing whatsoever:  (a) arising from the beginning of time up to the date you sign this Release Agreement including, but not limited to, any Employee Claims (i) relating in any way to your employment relationship with the Company or any of the Releasees or (ii) arising under any federal, local or state statute or regulation, including, without limitation, state wage and hour laws (to the extent waivable), federal and state whistleblower laws, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Lilly Ledbetter Fair Pay Act of 2009, the Equal Pay Act, the Americans with Disabilities Act, the Family and Medical Leave Act, the Employee Retirement Income Security Act (excluding COBRA), the Vietnam Era Veterans Readjustment Assistance Act, the Fair Credit Reporting Act, the Age Discrimination in Employment Act ("ADEA"), the Occupational Safety and Health Act, the Sarbanes-Oxley Act of 2002, the False Claims Act, the Texas Commission on Human Rights Act, the New Jersey Law Against Discrimination, the New Jersey Family Leave Act, the New Jersey State Wage and Hour Law (to the extent waivable), as each may be amended from time to time, any claim or cause of action you may have under any federal or state immigration statute, including without limitation the Immigration & Nationality Act ("INA"), the Immigration Reform & Control Act ("IRCA") and related regulations, and/or any other applicable local, state or federal law, each as amended; (b) relating to the termination of your employment relationship with the Company or any of the Releasees; (c) relating to wrongful employment termination; or (d) arising under or relating to any policy, agreement, understanding or promise, written or oral, formal or informal, between the Company, or any of the Releasees, and you, including, the Offer Letter dated November 14, 2012 and revised November 18, 2012 (the "Offer Letter"), attached as Exhibit A to this Release Agreement, and the Promotion Letter dated October 23, 2013 (the "Promotion Letter"), attached as Exhibit B.  This releases all Employee Claims including those of which you are not aware and those not mentioned in this Release Agreement.  You specifically release any and all Employee Claims arising out of your employment with the Company and/or any of its affiliates or termination therefrom, including, without limitation, any and all claims to monetary recovery to which you might be 

entitled in connection with any potential class action claims that may be filed on behalf of any purported class to which you are a member as a result of your employment with the Company and/or any of its affiliates.
6.You expressly acknowledge and agree that, by entering into this Release Agreement, you are releasing and waiving any and all rights or Employee Claims, including claims under the ADEA, which have arisen on or before the date your execution and delivery of this Release Agreement to the Company.
7.The Company, for itself and its successors, assigns, executors and administrators, now and forever hereby releases and discharges you, from any and all known rights, claims, charges, actions, causes of action, complaints, sums of money, suits, debts, covenants, contracts, agreements, promises, obligations, damages, demands or liabilities of every kind whatsoever, in law or in equity (collectively, "Company Claims") which the Company ever had, now has or may hereafter claim to have by reason of any matter, cause or thing whatsoever:  (a) arising from the beginning of time up to the date you sign this Release Agreement including, but not limited to, any currently known Company Claims (i) relating in any way to your employment relationship with the Company or any of the Releasees or (ii) arising under any federal, local or state statute or regulation; (b) relating to the termination of your employment relationship with the Company or any of the Releasees; or (c) arising under or relating to any policy, agreement, understanding or promise, written or oral, formal or informal, between the Company, or any of the Releasees, and you, including, the Offer Letter and Promotion Letter.  The Company does not release Company Claims arising from any intentional conduct on your part outside the course and scope of your employment, which have accrued or which may ever accrue to the Company or any of the Releasees resulting from or relating to any act or omission occurring on or before the date of signing this Agreement, arising out of or pertaining to your employment relationship with the Company, concerning the terms and conditions of your employment, or concerning your conduct occurring in the course and scope of your employment with the Company.  
8.Notwithstanding the foregoing, nothing contained in this Release Agreement shall in any way release or discharge any Employee Claims you may have (1) for payments or benefits set forth in the Release Agreement; (2) for indemnification under the charter, by-laws, certificate of formation, operating agreement or other governing documents of the Company, insurance policies of or pertaining to the Company, or applicable law; (3) for any vested pension or retirement benefits (including, without limitation, 401(k)); or (4) for any other Employee Claims that cannot be waived under applicable law.
9.You acknowledge and agree that, except as otherwise expressly provided in this Release Agreement:  (a) the Company has fully satisfied any and all obligations whatsoever owed to you arising out of your employment with the Company, and that no further payments or benefits are owed to you by the Company or any of the Releasees, including, but not limited to, any payments or benefits under the Offer Letter or the Promotion Letter; and (b) you have knowingly relinquished, waived and forever released any and all rights to any personal recovery in any action or proceeding that may be commenced on your behalf arising out of the aforesaid employment relationship or the termination thereof, including, without limitation, claims for backpay, front pay, liquidated damages, compensatory damages, general damages, special damages, punitive damages, exemplary damages, costs, expenses and attorneys' fees. 
10.You agree to indemnify the Company and hold it harmless for any claims brought by any taxing authority against any of the Releasees seeking payment of taxes, penalties and/or interest related to your reporting of taxes under federal, state and/or local law, including, without limitation, payment of attorneys' fees for counsel selected by the Company for its defense of such matters and costs.  For avoidance of doubt, this indemnification obligation does not extend to the Company’s withholding requirements related to the payments set forth in Paragraph 4.
11.You hereby represent and warrant that (a) you have not filed, caused or permitted to be filed any pending proceeding (nor have you lodged a complaint with any governmental or quasi-governmental 

authority) against any of the Releasees, nor have you agreed to do any of the foregoing, (b) you have not assigned, transferred, sold, encumbered, pledged, hypothecated, mortgaged, distributed, or otherwise disposed of or conveyed to any third party any right or Claim against any of the Releasees that has been released in this Release Agreement, and (c) you have not directly or indirectly assisted any third party in filing, causing or assisting to be filed, any Claim against any of the Releasees.  Except as set forth in Paragraph 12, 17 and 18 below, you covenant and agree that you shall not encourage or solicit or voluntarily assist or participate in any way in the filing, reporting or prosecution by you or any third party of a proceeding or Claim against any of the Releasees, including, but not limited to any potential class action claims that may be filed on behalf of any purported class to which you are a member as a result of your employment with the Company and/or any of its affiliates.
12.You and the Company acknowledge and agree that this Release Agreement shall not affect the rights and responsibilities of the Equal Employment Opportunity Commission (the "EEOC") or similar federal or state agency to enforce the ADEA or other applicable laws, and further acknowledge and agree that this Release Agreement shall not be used to justify interfering with your protected right to file a charge or participate in an investigation or proceeding conducted by the EEOC or similar federal or state agency.  Accordingly, nothing in this Release Agreement shall preclude you from filing a charge with, or participating in any manner in an investigation, hearing or proceeding conducted by, the EEOC or similar federal or state agency, but you hereby waive any and all rights to recover under, or by virtue of, any such investigation, hearing or proceeding.  Further notwithstanding anything set forth in this Release Agreement to the contrary, nothing in this Release Agreement shall affect or be used to interfere with your protected right to test in any court, under the Older Workers’ Benefit Protection Act, or like statute or regulation, the validity of the waiver of rights under the ADEA set forth in this Release Agreement.
Equity Awards
13.Subject to your continued compliance with the Covenants Agreement (as defined below and limited in Paragraph 14 herein) and the Assignment Agreement (defined below), Chiron Guernsey Holdings L.P. Inc., a Guernsey limited partners (the "Partnership") agrees that it will exercise its call right with respect to the Vested Profit Interest Units ("PIU") pursuant to Section VI.F. of the Amended and Restated Chiron Guernsey Holdings L.P. Inc. Executive Equity Incentive Plan (the "PIU Plan"), subject to the terms and conditions provided therein; provided, however, that the Partnership will make a payment to you in consideration for the cancellation of all of such Vested PIUs no later than April 30, 2015.  The purchase price for each Vested PIU will be equal to the Fair Market Value (as defined in the PIU Plan) as of the date that such payment is made to you in consideration for the cancellation of all of such Vested PIUs.

Covenants/Confidentiality
14.You acknowledge and agree that during your employment with the Company you have developed and had access to confidential trade secret information.  Accordingly, notwithstanding any provision of this Release Agreement to the contrary, you hereby reaffirm, and agree to comply with the Non-Disclosure and Non-Competition Agreement, signed by you as of December 5, 2012, a copy of which is attached hereto as Exhibit C (the "Covenants Agreement") and the Invention Assignment Agreement, signed by you as of December 5, 2012, a copy of which is attached hereto as Exhibit D (the "Assignment Agreement"); provided, however, that the Covenants Agreement is hereby, as applicable, limited as follows:
(a)    Subject to Paragraph 14(b) below, the restrictions in Section 3 of the Covenants Agreement (Non-Competition) shall not prevent you from performing services for a diversified company (or division thereof) that competes with the Company so long as (i) the division or department to which 

you are providing services does not compete with the Company, (ii) you do not have direct responsibility (commercial or technical) for the products of such diversified company (or division thereof) that are competitive with the products of the Company, and (iii) no more than thirty-five percent (35%) of such entity’s gross revenue is derived from such competitive business.
(b)    In the event that you do secure new employment in a diversified company as permitted by Paragraph 14(a), you shall not be permitted to use or disclose any Company Confidential Information or know how, in accordance with the Covenants Agreement, as part of your responsibilities in this role. 
You affirm that you are not currently seeking and will not seek employment in breach of your Covenants Agreement (as limited by this Paragraph 14).  You reaffirm that your experience and capabilities are such that the restrictions contained in the Covenants Agreement (as limited by this Paragraph 14) are reasonable, do not impose a greater restraint than necessary to protect the Company’s goodwill or other business interests and will not prevent you from obtaining employment or otherwise earning a reasonable living.  You further agree that the Covenants Agreement (as limited by this Paragraph 14) and Assignment Agreement shall remain in full force and effect as if restated herein.  
15.You agree not to take any action or to make any statement, written or oral, that disparages or criticizes the business or management of the Company or any of its respective directors, officers, agents, or employees.  Except as required or permitted by Paragraphs 12, 17 and 18, you further agree not to take any action that is intended to, or that does in fact, damage the business or reputation of the Company or its affiliates, or the personal or business reputations of any of their respective directors, officers, agents, or employees, or that interferes with, impairs or disrupts the normal operations of the Company or its affiliates.  The Company agrees to instruct the Acelity Senior Leadership Team not to take any action or to make any statement, written or oral, that disparages or criticizes you.
16.You agree that you will not disclose this Release Agreement or its terms to any person, except (a) to your immediate family, provided that prior to such disclosure, you inform your immediate family that they are also bound by confidentiality and you shall be responsible for any such disclosure by your immediate family; (b) as may be required for obtaining legal or tax advice, or future employment provided that prior to such disclosure you will inform your legal or tax advisor that they are bound by confidentiality and you shall be responsible for any such disclosure by your legal or tax advisor or potential employer; (c) for the filing of income tax returns; (d) as may be required by law, provided that you shall promptly notify the Company prior to making any disclosure required by law so that the Company may seek a protective order or other appropriate remedy; or (e) in any proceeding to enforce this Release Agreement.
17.You agree that following your termination of employment with Company, you will, at the Company’s request, cooperate fully, at such times that do not unreasonably interfere with your personal or business activities, with the Company in any regulatory or legal matter that involves the Company, or its then-current or former officers, directors, employees or agents, about which you may have knowledge or information.  The Company shall pay for your actual, documented expenses, if any, incurred for any such cooperation.  Your cooperation may include, but not be limited to, the following: (a) appearing for an interview; (b) answering all questions fully and truthfully; (c) appearing for depositions and/or at trial related to any claim, action or litigation in which the Company becomes a party; and (d) meeting with representatives of the Company to assist in preparation for such depositions and/or trials.
18.Nothing in this Release Agreement shall prevent you from providing truthful and accurate information to any government agency, internal regulating body or as otherwise may be required by law.

Return of Company Property
19.On or before the date you execute this Release Agreement, you will exercise reasonable efforts to return all property in your possession, custody or control which belongs to the Company, including without limitation, keys, credit cards, computers, phone cards and other physical property of the Company, and any of the Company’s documents, reports, files, memorandum, records, software and other media, whether kept in paper or electronic format, and neither you nor anyone acting on your behalf shall maintain copies, duplicates, reproductions or excerpts of any such property.  
Voluntary Waiver
20.You understand and agree that the Company is under no obligation to provide the payments and benefits provided in Paragraph 4 of this Release Agreement absent your consent to the terms of this Release Agreement, and that you are under no obligation to consent to this Release Agreement.  
21.You acknowledge and agree that (a) the Company has advised you of your right to consult with an attorney prior to executing this Release Agreement, (b) you have carefully read and fully understand all of the provisions of this Release Agreement, and (c) you are entering into this Release Agreement knowingly, freely and voluntarily in exchange for good and valuable consideration.  
22.You shall have twenty-one (21) calendar days from the date you are provided this Release Agreement, as amended, to consider this Release Agreement.  Once you have signed this Release Agreement, you shall have seven (7) additional calendar days from the date of execution to revoke your consent to this Release Agreement.  Any such revocation shall be made in writing so as to be received by David Lillback, Senior Vice President, Human Resources, prior to the eighth (8th) calendar day following your execution of this Release Agreement.  If no such revocation occurs, this Release Agreement shall become effective on the eighth (8th) calendar day following your execution of this Release Agreement (the "Effective Date").  In the event that you revoke your consent or you do not sign this Release Agreement within the applicable review period, this Release Agreement shall be null and void, and the Company shall not be obligated to provide you with any of the payments or benefits set forth in Paragraph 4 of this Release Agreement.
Governing Law; Dispute Resolution
23.This Release Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Texas, without reference to its choice of law rules.  
24.No waiver by either party of any breach by the other party of any condition or provision of this Release Agreement to be performed by such other party shall be deemed a waiver of any other provision or condition at the time or at any prior or subsequent time.  This Release Agreement and the provisions contained in it shall not be construed or interpreted for or against either party because that party drafted or caused that party's legal representative to draft any of its provisions.
25.Any claim or controversy arising out of or relating to this Release Agreement, your employment with or separation from the Company, or arising out of any other transaction or occurrence with the Releasees, shall be submitted to final and binding arbitration in Bexar County, Texas according to the procedures set out in the Company’s Arbitration Agreement and Agreement Concerning Policy on Arbitration, signed by you as of December 5, 2012, a copy of which is attached hereto as Exhibit E.  With an adequate opportunity to consult with legal counsel, you have knowingly and voluntarily waived any right to trial by jury of any dispute with any of the Releasees, notwithstanding contrary provisions of any federal, state or local law, regulation or ordinance.  Notwithstanding the foregoing provisions, if you breach any of your restrictive covenants, the Company shall have the right to seek immediate injunctive relief in the form of a 

temporary restraining order or preliminary injunction, enjoining you from such further breach of those provisions of this Release Agreement, pending a final ruling by the arbitrator.  
No Admission of Wrongdoing
26.Nothing contained in this Release Agreement shall be deemed to constitute an admission or evidence of any wrongdoing or liability by you or by the Company or any of the other Releasees.
Enforceability
27.In the event that any one or more of the provisions of this Release Agreement, including the Exhibits hereto, are held to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remainder hereof will not in any way be affected or impaired thereby and any such provision or provisions will be enforced to the fullest extent permitted by law.  Moreover, if any one or more of the provisions contained in this Release Agreement, including the Exhibits hereto, shall be held to be excessively broad as to duration, activity or subject, such provisions shall be construed by limiting and reducing them so as to be enforceable to the maximum extent allowed by applicable law.  
Successors and Assigns
28.This Release Agreement shall inure to the benefit of and be binding upon the Company and any successor organization which shall succeed to the Company by merger or consolidation or operation of law, or by acquisition of assets of the Company.  This Release Agreement is personal to you and may not be assigned by you.  In the event of your death prior to the Company’s having made or paid to you any or all of the payments and benefits referenced in this Release Agreement, the Company shall instead make or pay to your estate, as and when otherwise due hereunder, all such then remaining payments and benefits.
Entire Agreement
29.The terms described in this Release Agreement, including in the Exhibits (if applicable) hereto, set forth the entire agreement and understanding of the parties and supersede all prior agreements, arrangements and understandings, written or oral, between the parties, including, but not limited to, the Offer Letter and the Promotion Letter, provided, however, that as specifically provided in Paragraphs 13, 14 and 25 above, the PIU Plan, the Covenants Agreement (as limited by Paragraph 14 of this Agreement), the Assignment Agreement and the Arbitration Agreement remain in full force and effect.  You acknowledge and agree that you are not relying on any representations or promises by the Company, other than those set forth herein, with regard to the subject matter, basis or effect of this Release Agreement or otherwise.  This Release Agreement may not be altered or modified other than in a writing signed by you and an authorized representative of the Company.

*        *        *

Please indicate your agreement to the foregoing terms by signing and dating the Release Agreement in the space provided below.  If you decide to revoke your consent to the Release Agreement, it must be in writing and received by the Company as provided in Paragraph 22.
Very truly yours,

LifeCell Corporation

By:        /s/ David Lillback                            
David Lillback
Sr. Vice President, Human Resources

Agreed to and Accepted By:

/s/ Philip Croxford                
Philip Croxford

Date:    November 3, 201410.42 Amendment No. 6 to the Credit Agreement

    
AMENDMENT NO. 6 TO CREDIT AGREEMENT
AMENDMENT NO. 6, dated as of March 10, 2015 (this “Amendment”), by and among the Co-Borrowers, the Guarantors, the Parent GP, the Required Lenders and the Administrative Agent, to the Credit Agreement, dated as of November 4, 2011, as amended by Amendment No. 1 to Credit Agreement, dated November 7, 2012, Amendment No. 2 to Credit Agreement, dated June 14, 2013, Amendment No. 3 to Credit Agreement, dated October 28, 2013, Amendment No. 4 to Credit Agreement, dated November 15, 2013, and Amendment No. 5 to Credit Agreement, dated January 22, 2014, among CHIRON MERGER SUB, INC., a Texas corporation, KINETIC CONCEPTS, INC., a Texas corporation (the “Lead Borrower”), KCI USA, INC., a Delaware corporation (“KCI USA” and, together with the Lead Borrower, the “Co-Borrowers”), CHIRON HOLDINGS, INC., a Delaware corporation, CHIRON TOPCO, INC., a Delaware corporation, ACELITY L.P. INC., a Guernsey limited partnership, solely with respect to Sections 5.01 through 5.04, 7.13 and 8.01 of the Credit Agreement, CHIRON GUERNSEY GP CO. LIMITED, a Guernsey limited company, BANK OF AMERICA, N.A., as administrative agent, collateral agent, letter of credit issuer and swing line lender, and each lender from time to time party thereto (the “Credit Agreement”).  Terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement unless otherwise defined herein.
W I T N E S S E T H:
WHEREAS, the Lead Borrower has requested an amendment to the Credit Agreement and the Guaranty Agreement pursuant to which certain provisions of the Credit Agreement and the Guaranty Agreement will be amended as set forth herein;
NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 
ARTICLE I

Amendments

Section 1.1.     Amendments.  Subject to the occurrence of the Amendment No. 6 Effective Date: 

(a)Section 1.01 of the Credit Agreement is hereby amended by inserting in appropriate alphabetical order the following new definitions:

“Amendment No. 6” means Amendment No. 6 to this Agreement dated as of March 10, 2015.
“Amendment No. 6 Effective Date” means March 10, 2015, the date of effectiveness of Amendment No. 6.
“Commodity Exchange Act” means the Commodity Exchange Act (7 U.S.C. § 1 et seq.), as amended from time to time, and any successor statute.
“Excluded Swap Obligation” means, with respect to any Guarantor, any Swap Obligation if, and solely to the extent that, all or a portion of the Guarantee of such Guarantor of, or the grant by such Guarantor of a security interest pursuant to the Collateral Documents to secure, such Swap Obligation (or any Guarantee thereof) is or becomes illegal or unlawful under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by virtue of such Guarantor’s failure for any reason to constitute an “eligible contract participant” (determined after giving effect to any applicable keep well, support or other agreement for the benefit of such Guarantor and any and all Guarantees of such Guarantor’s Swap Obligations by other Loan Parties) as defined in the 

Commodity Exchange Act at the time the Guarantee of such Guarantor or the grant of such security interest would otherwise have become effective with respect to such related Swap Obligation but for such Guarantor’s failure to constitute an “eligible contract participant” at such time. If a Swap Obligation arises under a Master Agreement governing more than one Swap, such exclusion shall apply only to the portion of such Swap Obligation that is attributable to Swaps for which such Guarantee or security interest is or becomes excluded in accordance with the first sentence of this definition.
“Financial Covenant” means the covenant set forth in Section 7.10.
“Permitted Alternative Incremental Facilities Debt” has the meaning specified in Section 7.03(t).
“Swap Obligation” means, with respect to any Guarantor, any obligation to pay or perform under any agreement, contract or transaction that constitutes a “swap” within the meaning of section 1a(47) of the Commodity Exchange Act.
(b)Clause (b) of the definition of “Applicable Rate” is hereby amended and restated in its entirety as follows:

“(i) for Eurocurrency Rate Loans that are Dollar Term E-1 Loans, 3.50%, (ii) for Base Rate Loans that are Dollar Term E-1 Loans, 2.50%, (iii) for Eurocurrency Rate Loans that are Euro Term E-1 Loans, 3.75%, (iv) for Base Rate Loans that are Euro Term E-1 Loans, 2.75%, (v) for Eurocurrency Rate Loans that are Term E-2 Loans, 3.00%, and (vi) for Base Rate Loans that are Term E-2 Loans, 2.00%.”
(c)The definition of “Excluded Taxes” in the Credit Agreement is hereby amended by amending and restating clause (d) thereof in its entirety and replacing it with the following: 

“(d) any withholding Tax imposed pursuant to FATCA.”
(d)The definition of “FATCA” in the Credit Agreement is hereby amended and restated in its entirety as follows:

““FATCA” means Sections 1471 through 1474 of the Code as of the date of this Agreement (or any amended or successor version that is substantively comparable thereto), any current or future Treasury regulations thereunder or other official administrative interpretations thereof, any agreements entered into pursuant to current Section 1471(b)(1) of the Code as of the date of this Agreement (or any amended or successor version described above) and any intergovernmental agreements implementing the foregoing.”
(e)The definition of “Financial Covenants” in the Credit Agreement is hereby deleted in its entirety.

(f)The definition of “Repricing Transaction” in the Credit Agreement is hereby amended by amending and restating subclause (a)(ii) in the first sentence thereof in its entirety and replacing it with the following:

“(ii) Indebtedness in the form of loans incurred under Section 7.03(x)”
(g)Section 2.05(a)(ii) of the Credit Agreement is hereby amended by inserting the following immediately after clause (7) thereof:

“(8)  on or prior to the twelve month anniversary of the Amendment No. 6 Effective Date, the Co-Borrowers (i) make any prepayment of Dollar Term E-1 Loans, Euro Term E-1 Loans or Term E-2 Loans in connection with any Repricing Transaction or (ii) effect any amendment of this Agreement resulting in a Repricing Transaction with respect to Dollar Term E-1 Loans, Euro Term E-1 Loans or Term E-2 Loans, the Co-Borrowers shall pay to the Administrative Agent, for the ratable account of 

each of the applicable Dollar Term E-1 Lenders, Euro Term E-1 Lenders or Term E-2 Lenders, (x) in the case of clause (i), a prepayment premium of 1.0% of the amount of the applicable Dollar Term E-1 Loans, Euro Term E-1 Loans or Term E-2 Loans being prepaid and (y) in the case of clause (ii), an amount equal to 1.0% of the aggregate amount of the applicable Dollar Term E-1 Loans, Euro Term E-1 Loans or Term E-2 Loans outstanding immediately prior to such amendment.”
(h)Section 2.14(a) of the Credit Agreement is hereby amended and restated in its entirety as follows:

 “(a)    At any time and from time to time, subject to the terms and conditions set forth herein, the Borrowers may, by notice to the Administrative Agent (whereupon the Administrative Agent shall promptly deliver a copy to each of the Lenders), request to add one or more additional tranches of term loans (the “Incremental Term Loans”) or one or more increases in the Revolving Credit Commitments (the “Incremental Revolving Commitments”; together with the Incremental Term Loans, the “Incremental Facilities”), provided that at the time of each such request and upon the effectiveness of each Incremental Facility Amendment no Default or Event of Default has occurred and is continuing or shall result therefrom.  Notwithstanding anything to contrary herein, the aggregate principal amount of all Incremental Facilities (other than Refinancing Term Loans and Refinancing Revolving Commitments), together with the aggregate principal amount of all Permitted First Lien Secured Debt and Permitted Alternative Incremental Facilities Debt, shall not exceed the sum of (x) $350,000,000 plus (y) the amount of any voluntary prepayments of the Term Loans and voluntary permanent reductions of the Revolving Credit Commitments effected after the Closing Date (it being understood that any prepayment of Term Loans with the proceeds of substantially concurrent borrowings of new Loans hereunder or any reduction of Revolving Credit Commitments in connection with a substantially concurrent issuance of new revolving commitments hereunder shall not increase the calculation of the amount under this clause (y)); provided that (i) the Borrowers may incur unlimited additional Incremental Facilities, Permitted First Lien Secured Debt and Permitted Alternative Incremental Facilities Debt so long as, after giving Pro Forma Effect thereto (assuming that any such Incremental Revolving Commitments are drawn in full) and after giving effect to any Permitted Acquisition consummated in connection therewith and all other appropriate Pro Forma Adjustments, the First Lien Senior Secured Leverage Ratio shall not exceed 3.25:1.00 (other than to the extent such Incremental Facilities, Permitted First Lien Secured Debt or Permitted Alternative Incremental Facilities Debt is incurred pursuant to this proviso concurrently with the incurrence of Incremental Facilities, Permitted First Lien Secured Debt or Permitted Alternative Incremental Facilities Debt in reliance on clause (x) above, in which case the First Lien Senior Secured Leverage Ratio shall be permitted to exceed 3.25:1.00 to the extent of such Incremental Facilities, Permitted First Lien Secured Debt or Permitted Alternative Incremental Facilities Debt is incurred in reliance on such clause (x)) and (ii) for the avoidance of doubt, Incremental Facilities, Permitted First Lien Secured Debt or Permitted Alternative Incremental Facilities Debt may be incurred pursuant to clause (i) of this proviso prior to utilization of the amount set forth in clause (x) above. Each Incremental Facility shall be in an integral multiple of $1,000,000 and be in an aggregate principal amount that is not less than $15,000,000 in case of Incremental Term Loans or $15,000,000 in case of Incremental Revolving Commitments, provided that such amount may be less than the applicable minimum amount if such amount represents all the remaining availability hereunder as set forth above.  Each Incremental Facility shall have the same guarantees as, and be secured by the same Collateral securing, all of the other Obligations hereunder.”
(i)Section 3.01(f) of the Credit Agreement is hereby amended by (w) changing the comma at the end of subclause (ii)(E) to a semicolon and (x) adding the following clause (iii) at the end thereof:

“(iii)    If a payment made to any Lender under any Loan Documents would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as 

applicable), such Lender shall deliver to the Borrowers and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrowers or the Administrative Agent such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrowers or the Administrative Agent as may be necessary for the Borrowers and the Administrative Agent to comply with their obligations under FATCA, to determine whether such Lender has or has not complied with such Lender’s obligations under FATCA and, if necessary, to determine the amount to deduct and withhold from such payment.  Solely for purposes of this clause (iii), “FATCA” shall include any amendments made to FATCA after the date of this Agreement.”
(j)Section 7.01(ee) of the Credit Agreement is hereby amended by (i) deleting the following parenthetical at the end of clause (x) thereof:

“(and the terms set forth in the proviso in Section 2.14(b) shall have been complied with as if such Indebtedness was considered an Incremental Term Loan)”
and (ii) deleting the following parenthetical at the end of clause (y) thereof:
“(unless such term loans are non-amortizing and the terms and conditions of which (excluding pricing and optional and mandatory prepayment or redemption terms) reflect market terms on the date of issuance)”
(k)Section 7.01 of the Credit Agreement is hereby amended by deleting the “and” at the end of clause (ff) thereof, deleting the period at the end of clause (gg) thereof and replacing it with “; and” and inserting the following immediately after clause (gg) thereof:

“(hh)    Liens securing Indebtedness permitted pursuant to Section 7.03(t); provided that such Liens may be either a first priority Lien on the Collateral that is pari passu with the Lien securing the Obligations or a Lien ranking junior to the Lien on the Collateral securing the Obligations (but may not be secured by any assets that are not Collateral) and, in any such case, the beneficiaries thereof (or an agent on their behalf) shall have, as applicable, (i) become party to the Notes Intercreditor Agreement pursuant to the terms thereof or (ii) entered into an intercreditor agreement with the Administrative Agent that is reasonably satisfactory to the Administrative Agent.”
(l)Section 7.03(t) of the Credit Agreement is hereby amended and restated in its entirety as follows:

“(t)    (i) Indebtedness (in the form of senior secured, senior unsecured, senior subordinated, or subordinated notes or loans) incurred by the Borrowers to the extent that the Borrowers shall have been permitted to incur such Indebtedness pursuant to, and such Indebtedness shall be deemed to be incurred in reliance on, Section 2.14 (assuming for such purposes that such Indebtedness was an Incremental Term Loan that is secured by a first priority lien on the Collateral); provided that (A) such Indebtedness shall not mature earlier than the Maturity Date applicable to the Term E-1 Loans, (B) as of the date of the incurrence of such Indebtedness, the Weighted Average Life to Maturity of such Indebtedness shall not be shorter than that of the then-remaining Term E-1 Loans, (C) no Restricted Subsidiary is a borrower or guarantor with respect to such Indebtedness unless such Restricted Subsidiary is a Subsidiary Guarantor which shall have previously or substantially concurrently Guaranteed the Obligations, (D) the other terms and conditions of such Indebtedness (excluding pricing and optional prepayment or redemption terms) reflect market terms on the date of issuance; provided that if such Indebtedness contains any financial maintenance covenants, such covenants shall not be tighter than (or in addition to) those contained in this Agreement, (E) if such Indebtedness is in the form of a credit facility that could have been incurred as an Incremental Term Loan and incurred or guaranteed on a secured basis, then such Indebtedness shall be subject to the terms set forth in the proviso in Section 2.14(b) as if such Indebtedness was considered an Incremental Term Loan and (F) 

the Lead Borrower has delivered to the Administrative Agent a certificate of a Responsible Officer, together with all relevant financial information reasonably requested by the Administrative Agent, including reasonably detailed calculations demonstrating compliance with clauses (A), (B), (C), (D) and (E) (such Indebtedness incurred pursuant to this clause (t) being referred to as “Permitted Alternative Incremental Facilities Debt”) and (ii) any Permitted Refinancing thereof;”

(m)Section 7.05(m)(iii) of the Credit Agreement is hereby amended and restated in its entirety as follows:

“(iii)    from and after the Amendment No. 6 Effective Date, all such Dispositions made under this Section 7.05(m) do not exceed in the aggregate 15.0% of Total Assets for the Test Period then most recently ended;”
(n)Section 7.10 of the Credit Agreement is hereby amended and restated in its entirety as follows: 

“Financial Covenant.  Permit the Total Leverage Ratio for any Test Period to be greater than 8.25:1.00.”
(o)Section 10.10 of the Credit Agreement is hereby amended and restated by inserting the following paragraph after the first paragraph in such Section:

“The words “execution,” “execute,” “signed,” “signature,” and words of like import in or related to any document to be signed in connection with this Agreement and the transactions contemplated hereby (including without limitation Assignment and Assumptions, amendments or other Committed Loan Notices, Swingline Loan Notices, waivers and consents) shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act; provided that notwithstanding anything contained herein to the contrary the Administrative Agent is under no obligation to agree to accept electronic signatures in any form or in any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved by it.” 
(p)Article IV of the Guaranty Agreement is hereby amended by inserting the following as a new Section 4.15:

“Excluded Swap Obligations Limitation. Notwithstanding anything in this Guaranty to the contrary, no Guarantor shall be required to make any payment pursuant to this Guaranty to any party, and the right of set-off provided in Section 4.08 shall not apply with respect to any Guarantor, in each case, with respect to Excluded Swap Obligations, if any, of such Guarantor.”
(q)The definition of “Obligations” in the Credit Agreement is hereby amended and restated in its entirety as follows:

““Obligations” means all (x) advances to, and debts, liabilities, obligations, covenants and duties of, any Loan Party or other Subsidiary arising under any Loan Document or otherwise with respect to any Loan or Letter of Credit, whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including interest and fees that accrue after the commencement by or against any Loan Party or any other Subsidiary of any proceeding under any Debtor Relief Laws naming such Person as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such proceeding, (y) obligations of any Loan Party or any other Subsidiary arising under any Secured Hedge Agreement, and (z) Cash 

Management Obligations; provided that the “Obligations” shall exclude any Excluded Swap Obligations.  Without limiting the generality of the foregoing, the Obligations of the Loan Parties under the Loan Documents (and of any of their Subsidiaries to the extent they have obligations under the Loan Documents) include (a) the obligation (including guarantee obligations) to pay principal, interest, Letter of Credit commissions, reimbursement obligations, charges, expenses, fees, Attorney Costs, indemnities and other amounts payable by any Loan Party or any other Subsidiary under any Loan Document and (b) the obligation of any Loan Party or any other Subsidiary to reimburse any amount in respect of any of the foregoing that any Lender, in its sole discretion, may elect to pay or advance on behalf of such Loan Party or such Subsidiary.”
(r)Section 8.04 of the Credit Agreement is hereby amended by inserting the following paragraph after the last paragraph in such Section:

“Notwithstanding the foregoing, (a) amounts received from any Borrower or any Guarantor that is not a “Eligible Contract Participant” (as defined in the Commodity Exchange Act) shall not be applied to the obligations that are Excluded Swap Obligations (it being understood, that in the event that any amount is applied to Obligations other than Excluded Swap Obligations as a result of this clause (a), to the extent permitted by applicable law, the Administrative Agent shall make such adjustments as it determines are appropriate to distributions pursuant to clause Fourth above from amounts received from “Eligible Contract Participants” to ensure, as nearly as possible, that the proportional aggregate recoveries with respect to obligations described in clause Fourth above by the holders of any Excluded Swap Obligations are the same as the proportional aggregate recoveries with respect to other obligations pursuant to clause Fourth above) and (b) Cash Management Obligations shall be excluded from the application described above if the Administrative Agent has not received written notice thereof, together with such supporting documentation as the Administrative Agent may request, from the applicable Cash Management Bank. Each Cash Management Bank not a party to this Agreement that has given the notice contemplated by the preceding sentence shall, by such notice, be deemed to have acknowledged and accepted the appointment of the Administrative Agent pursuant to the terms of Article IX hereof for itself and its Affiliates as if a “Lender” party hereto.”
(s)Section 1.02 of the Guaranty Agreement is hereby amended by inserting in appropriate alphabetical order the following new definition:

“Qualified ECP Guarantor” means, in respect of any Swap Obligation, each Guarantor that has total assets exceeding $10,000,000 at the time the relevant Guarantee or grant of the relevant security interest becomes effective with respect to such Swap Obligation is incurred or such other person as constitutes an “eligible contract participant” under the Commodity Exchange Act or any regulations promulgated thereunder and can cause another person to qualify as an “eligible contract participant” at such time by entering into a keepwell under Section 1a(18)(A)(v)(II) of the Commodity Exchange Act.
(t)Section 2.01 of the Guaranty Agreement is hereby amended and restated in its entirety as follows:

“Guaranty and Keepwell. 
(a)     Each Guarantor absolutely, irrevocably and unconditionally guarantees, jointly with the other Guarantors and severally, as a primary obligor and not merely as a surety, the due and punctual payment and performance of the Obligations. Each of the Guarantors further agrees that the Obligations may be extended or renewed, in whole or in part, without notice to or further assent from it, and that it will remain bound upon its guarantee notwithstanding any extension or renewal of any Obligation. Each of the Guarantors waives presentment to, demand of payment from and protest to any Co-Borrower or any other Guaranty Party of any of the Obligations, and also waives notice of acceptance of its guarantee and notice of protest for nonpayment.

(b)     Each Qualified ECP Guarantor hereby jointly and severally absolutely, unconditionally and irrevocably undertakes to provide such funds or other support as may be needed from time to time by each other Loan Party to honor all of its obligations under this Guaranty in respect of Swap Obligations (provided, however, that each Qualified ECP Guarantor shall only be liable under this Section 2.01(b) for the maximum amount of such liability that can be hereby incurred without rendering its obligations under this Section 2.01(b), or otherwise under this Guaranty, voidable under applicable Law relating to fraudulent conveyance or fraudulent transfer, and not for any greater amount). The obligations of each Qualified ECP Guarantor under this Section 2.01(b) shall remain in full force and effect until the termination of this Guaranty in accordance with Section 4.13. Each Qualified ECP Guarantor intends that this Section 2.01(b) constitute, and this Section 2.01(b) shall be deemed to constitute, a guarantee of the obligations of, and a “keepwell, support, or other agreement” for the benefit of each other Loan Party for all purposes of Section 1a(18)(A)(v)(II) of the Commodity Exchange Act.”
ARTICLE II

Conditions to Effectiveness

This Amendment shall become effective on the date (the “Amendment No. 6 Effective Date”) on which:
(a)The Administrative Agent (or its counsel) shall have received from (i) the Administrative Agent, (ii) the Required Lenders and (iii) each Loan Party and the Parent GP, (x) a counterpart of this Amendment signed on behalf of such party or (y) written evidence satisfactory to the Administrative Agent (which may include a telecopy or other electronic transmission of a signed signature page of this Agreement) that such party has signed a counterpart of this Agreement.

(b)The Administrative Agent shall have received, on behalf of itself, the Collateral Agent, the Lenders and each L/C Issuer on the Amendment No. 6 Effective Date, a written opinion of (i)  Kirkland & Ellis LLP, New York counsel to the Loan Parties and (ii) Cox Smith Matthews Incorporated, Texas counsel to the Loan Parties, in each case (A) dated as of the Amendment No. 6 Effective Date, (B) addressed to each L/C Issuer on the Amendment No. 6 Effective Date, the Administrative Agent, the Collateral Agent and the Lenders and (C) in form and substance reasonably satisfactory to the Administrative Agent

(c)The Administrative Agent shall have received a copy of the certificate or articles of incorporation, certificate of limited partnership, certificate of formation or other equivalent organizational documents, including all amendments thereto, of each Loan Party and the Parent GP, (A) in the case of a corporation, certified as of a recent date by the Secretary of State (or other similar official) of the jurisdiction of its organization, and a certificate as to the good standing (to the extent such concept or a similar concept exists under the laws of such jurisdiction) of each such Loan Party or the Parent GP as of a recent date from such Secretary of State (or other similar official) or (B) in the case of a partnership or limited liability company, certified by the Secretary or Assistant Secretary of each such Loan Party or the Parent GP, or in the alternative (other than in the case of the Co-Borrowers), a certificate stating that such certificate or articles of incorporation or organization have not been amended since the Amendment No. 5 Effective Date.

(d)The Administrative Agent shall have received in the case of each Loan Party and the Parent GP a certificate of the Secretary or Assistant Secretary or similar officer of each Loan Party and the Parent GP dated the Amendment No. 6 Effective Date and certifying (i) that attached thereto is a true and complete copy of the bylaws (or partnership agreement, limited liability company agreement or other equivalent governing documents) of such Loan Party or the Parent GP as in effect on the Amendment No. 6 Effective Date and at all times since a date prior to the date of the resolutions described in clause (ii) below or in the alternative (other than in the case of the Co-Borrowers), certifying that such bylaws (or partnership agreement, limited liability company agreement or other equivalent governing documents) have not been amended since the 

Amendment No. 5 Effective Date, (ii) that attached thereto is a true and complete copy of resolutions duly adopted by the Board of Directors of such Loan Party or the Parent GP (or its managing general partner, managing member or equivalent) authorizing the execution, delivery and performance of this Amendment or any other document delivered in connection herewith to which such person is a party and, in the case of the Co-Borrowers, the borrowings hereunder, and that such resolutions have not been modified, rescinded or amended and are in full force and effect on the Amendment No. 6 Effective Date, (iii) that the certificate or articles of incorporation, certificate of limited partnership, articles of incorporation, certificate of formation or other equivalent organizational documents of such Loan Party or the Parent GP has not been amended since the date of the last amendment thereto disclosed pursuant to clause (i) above, (iv) as to the incumbency and specimen signature of each officer executing this Amendment or any other document delivered in connection herewith on behalf of such Loan Party or the Parent GP, and (v) as to the absence of any pending proceeding for the dissolution or liquidation of such Loan Party or the Parent GP.

(e)The Administrative Agent shall have received in the case of each Loan Party and the Parent GP a certificate of a director or an officer as to the incumbency and specimen signature of the Secretary or Assistant Secretary or similar officer executing the certificate pursuant to clause (b) above.

(f)The Co-Borrowers shall have paid to the Administrative Agent for the account of each Lender that has executed and delivered a signature page to this Amendment No. 6 to the Administrative Agent at or prior to 5:00 p.m., New York City time on March 5, 2015 (the “Consent Deadline”) a fee equal to 0.25% of the sum of (x) the Term Loans, if any, of such Lender at the Consent Deadline and (y) the Revolving Credit Commitments, if any, of such Lender at the Consent Deadline.  All other fees and expenses due to the Administrative Agent and the Lenders required to be paid on the Amendment No. 6 Effective Date shall have been paid.  All reasonable costs and expenses (including, without limitation, the reasonable fees, charges and disbursements of counsel for the Administrative Agent) of the Administrative Agent in connection with this Amendment and the transactions contemplated hereby shall have been paid, to the extent invoiced.

(g)The representations and warranties set forth in the Loan Documents shall be true and correct in all material respects as of the date hereof, as applicable, with the same effect as though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date (in which case such representations and warranties shall be true and correct in all material respects as of such earlier date) provided that any representation and warranty that is qualified as to “materiality,” “Material Adverse Effect” or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such respective dates.

(h)At the time of and immediately after giving effect to this Amendment, no Default or Event of Default shall exist or would result from the Amendment and related Credit Extension or from the application of the proceeds therefrom.

(i)The Administrative Agent shall have received a certificate, dated the Amendment No. 6 Effective Date and signed by a Responsible Officer of the Lead Borrower, confirming compliance with the conditions set forth in paragraphs (g) and (h) of this Article II.

The Administrative Agent shall notify the Lead Borrower and the Lenders of the Amendment No. 6 Effective Date.  Notwithstanding the foregoing, the amendments effected hereby shall not become effective, and will automatically terminate, if each of the conditions set forth or referred to in this Article II has not been satisfied at or prior to 5:00 p.m., New York City time, on March 10, 2015.

ARTICLE III

Representations and Warranties.

After giving effect to the amendments contained herein, on the Amendment No. 6 Effective Date the Co-Borrowers hereby confirm that:  (a) this Amendment has been duly authorized, executed and delivered by each Loan Party and the Parent GP and constitutes the legal, valid and binding obligations of each Loan Party and the Parent GP enforceable against it in accordance with its terms, except as such enforceability may be limited by Debtor Relief Laws and by general principles of equity; (b) the representations and warranties set forth in Article III of the Credit Agreement are true and correct in all material respects on and as of the Amendment No. 6 Effective Date with the same effect as though made on and as of the Amendment No. 6 Effective Date, except to the extent such representations and warranties expressly relate to an earlier date (in which case such representations and warranties were true and correct in all material respects as of such earlier date); provided that any representation and warranty that is qualified as to “materiality,” “Material Adverse Effect” or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such respective dates; and (c) no Default or Event of Default has occurred and is continuing under the Credit Agreement.
ARTICLE IV

Miscellaneous

Section 4. 1.Continuing Effect; No Other Amendments or Waivers.  This Amendment shall not constitute an amendment or waiver of or consent to any provision of the Credit Agreement and the other Loan Documents except as expressly stated herein and shall not be construed as an amendment, waiver or consent to any action on the part of the Loan Parties or the Parent GP that would require an amendment, waiver or consent of the Administrative Agent or the Lenders except as expressly stated herein.  Except as expressly waived hereby, the provisions of the Credit Agreement and the other Loan Documents are and shall remain in full force and effect in accordance with their terms.  This Amendment shall constitute a “Loan Document” for all purposes of the Credit Agreement and the other Loan Documents.

Section 4. 2.Counterparts.  This Amendment may be executed in any number of separate counterparts by the parties hereto (including by telecopy or via electronic mail), each of which counterparts when so executed shall be an original, but all the counterparts shall together constitute one and the same instrument.

Section 4. 3.GOVERNING LAW.  THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

Section 4. 4.Reaffirmation.  Each Loan Party, and with respect to clause (i) below the Parent GP, hereby expressly acknowledges the terms of this Amendment and reaffirms, as of the date hereof, (i) the covenants and agreements contained in each Loan Document to which it is a party, including, in each case, such covenants and agreements as in effect immediately after giving effect to this Amendment and the transactions contemplated hereby and (ii) its guarantee of the Obligations under each Guaranty, as applicable, and its grant of Liens on the Collateral to secure the Obligations pursuant to the Collateral Documents.

Section 4. 5.From and after the Amendment No. 6 Effective Date, the Borrowers and the Administrative Agent shall treat (and the Lenders hereby authorize the Administrative Agent to treat) the Term Loans as not qualifying as a “grandfathered obligation” within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i).

Section 4. 6.On and after the Amendment No. 6 Effective Date, each reference in the Credit Agreement to “this Agreement,” “hereunder,” “hereof” or words of like import referring the Credit Agreement, and each reference in the Notes and each of the other Loan Documents to “the Credit Agreement,” “thereunder,” “thereof” 

or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement, as amended by this Amendment.

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered by their respective duly authorized officers as of the date first above written.
                        	
		
	KINETIC CONCEPTS, INC.,

	 
	as the Lead Borrower

	 
	 

	By:
	/s/ Thomas W. Casey

	 
	Name: Thomas W. Casey

	 
	Title: Executive Vice President, Chief Financial Officer and Treasurer

        	
		
	KCI USA, INC.,

	 
	as Co-Borrower

	 
	 

	By:
	/s/ Thomas W. Casey

	 
	Name: Thomas W. Casey

	 
	Title: Executive Vice President, Chief Financial Officer and Treasurer

                        	
		
	CHIRON HOLDINGS, INC.,

	 
	as Holdings

	 
	 

	By:
	/s/ Thomas W. Casey

	 
	Name: Thomas W. Casey

	 
	Title: Vice President and Treasurer

                        	
		
	CHIRON TOPCO, INC.,

	 
	as Topco

	 
	 

	By:
	/s/ Thomas W. Casey

	 
	Name: Thomas W. Casey

	 
	Title: Vice President and Treasurer

[Signature Page to Amendment No. 6]

                	
		
	KCI HOLDING COMPANY, INC.

	KCI HOMECARE, INC.

	KCI INTERNATIONAL, INC.

	KCI LICENSING, INC.

	KCI IMPORTS, INC.,

	 
	as a Guarantor

	 
	 

	By:
	/s/ Thomas W. Casey

	 
	Name: Thomas W. Casey

	 
	Title: Vice President and Treasurer

                        	
		
	KCI ANIMAL HEALTH, LLC

	KCI REAL HOLDINGS, L.L.C.

	KCI USA REAL HOLDINGS, L.L.C.

	TECHNIMOTION, LLC

	KCI PROPERTIES LIMITED

	KCI REAL PROPERTY LIMITED,

	 
	as a Guarantor

	 
	 

	By:
	/s/ Thomas W. Casey

	 
	Name: Thomas W. Casey

	 
	Title: Vice President and Treasurer

                        	
		
	LIFECELL CORPORATION,

	 
	as a Guarantor

	 
	 

	By:
	/s/ Thomas W. Casey

	 
	Name: Thomas W. Casey

	 
	Title: Executive Vice President, Chief Financial Officer and Treasurer

[Signature Page to Amendment No. 6]

    	
		
	ACELITY LP, INC., as Parent

	 
	 

	By:
	CHIRON GUERNSEY GP CO. LIMITED,

	 
	Its:  General Partner

	 
	 

	By:
	/s/ Thomas W. Casey

	 
	Name: Thomas W. Casey

	 
	Title: Director

                            	
		
	CHIRON GUERNSEY GP CO. LIMITED,

	 
	as the Parent GP

	 
	 

	By:
	/s/ Thomas W. Casey

	 
	Name: Thomas W. Casey

	 
	Title: Director

[Signature Page to Amendment No. 6]

    	
		
	BANK OF AMERICA, N.A.,

	 
	as Administrative Agent and Collateral Agent

	 
	 

	By:
	/s/ Anthony W. Kell

	 
	Name: Anthony W. Kell

	 
	Title: Vice President

                            

[Signature Page to Amendment No. 6]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]